We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for International Flavors' (IFF) Q3 Earnings?
Read MoreHide Full Article
International Flavors & Fragrances Inc. (IFF - Free Report) is scheduled to report third-quarter 2022 results on Nov 7 after the closing bell.
Q2 Performance
In the last reported quarter, International Flavors’ earnings and revenues beat the Zacks Consensus Estimates and increased year over year. The company has surpassed earnings estimates in all the trailing four quarters, the average surprise being 12.2%.
International Flavors & Fragrances Inc. Price and EPS Surprise
The Zacks Consensus Estimate for third-quarter revenues is currently pegged at $3.03 billion, indicating a year-over-year decline of 1.5%. The Zacks Consensus Estimate for the September-end quarter earnings per share is pegged at $1.30, suggesting a year-over-year decline of 11.6%.
Key Factors to Note
International Flavors has been gaining from favorable markets for flavors and fragrances, supported by demand for various consumer products and growth in emerging markets. New business wins and the synergies from the Frutarom acquisition are likely to have aided the company’s performance in the quarter to be reported.
The Nourish segment continues to deliver strong results, primarily driven by the Flavors, Ingredients and Food Design businesses. The Zacks Consensus Estimate for the segment’s sales for the third quarter is pegged at $1,703 million, projecting a 2.5% rise year over year. The consensus mark for the segment’s operating EBITDA is pegged at $328 million compared with the prior-year quarter’s $327 million.
The Scent segment has been witnessing sustained strength in Cosmetic Actives and Consumer Fragrances. Volumes have significantly picked up in the Fine Fragrance business, with consumer behavior returning to normal levels. These are likely to be reflected in the segment’s third-quarter top line.
The Zacks Consensus Estimate for the segment’s sales for the third quarter is currently pegged at $589 million compared with the year-ago quarter’s $580 million. The estimate for operating EBITDA for the segment is at $103 million, indicating year-over-year decline of 21%.
Evolving consumer buying trends are driving demand for the Home & Personal Care business, which might be reflected in the Health & Biosciences segment’s quarterly results. Growth in Grain Processing, Cultures & Food Enzymes and Animal Nutrition is expected to have contributed to the segment’s performance.
The Zacks Consensus Estimate for the Health & Biosciences segment’s sales for the third quarter is pegged at $562 million, suggesting a year-over-year decline of 9%. The estimate for the segment’s operating EBITDA is pegged at $150 million, down 1% from the year-ago quarter.
Strong growth in Industrial Pharma and the ongoing recovery in demand in Pharma are expected to have supported the Pharma Solutions segment in the to-be-reported quarter. The Zacks Consensus Estimate for the segment’s third-quarter sales is pegged at $219 million compared with the prior-year quarter’s $211 million. The estimate for the segment’s operating EBITDA stands at $49 million, indicating a year-over-year increase of 22.5%.
High raw material, energy and labor costs are likely to have impacted the company’s margins in the third quarter. Manufacturing expenses are anticipated to have been higher due to the company’s efforts to meet the current high demand levels.
Labor shortages and supply-chain disruptions might have impacted the company’s production in the to-be-reported quarter. Despite its pricing actions and cost reduction efforts, these factors are likely to have weighed on the company’s margins in the quarter under review.
Earnings Whispers
Our proven model doesn’t conclusively predict an earnings beat for International Flavors this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Earnings ESP: The Earnings ESP for International Flavors is -0.13%.
Zacks Rank: International Flavors currently carries a Zacks Rank #3.
In the past year, International Flavors’ shares have declined 33.9% compared with the industry’s fall of 39.7%.
Stocks to Consider
Here are some Consumer Staples stocks,which according to our model have the right combination of elements to post an earnings beat in their upcoming releases:
Dutch Bros (BROS - Free Report) currently has an Earnings ESP of +1.11% and a Zacks Rank #2. The company is expected to register top-line growth when it reports third-quarter 2022 results. The Zacks Consensus Estimate for Dutch Bros’ quarterly revenues is pegged at $196.3 million, indicating an improvement of 51.2% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Dutch Bros’ bottom line has moved down 25% in the past 30 days to 6 cents per share. The estimate suggests a decline of 73.9% from the year-ago quarter’s reported figure. BROS has delivered an earnings beat of 53%, on average, in the trailing four quarters.
US Foods (USFD) currently has an Earnings ESP of +4.58% and a Zacks Rank #2. The company is likely to register top-line growth when it reports third-quarter 2022 numbers. The Zacks Consensus Estimate for quarterly revenues is pegged at $8.6 billion, which suggests growth of 9.6% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for USFD’s third-quarter earnings has moved down 3% in the past 30 days to 59 cents per share. The estimate suggests an improvement of 23% from the year-ago quarter’s reported number.
Hershey (HSY - Free Report) currently has an Earnings ESP of +2.02% and a Zacks Rank of 3. The company is expected to register top-line growth when it reports the third-quarter 2022 numbers. The Zacks Consensus Estimate for HSY’s quarterly revenues is pegged at $2.6 billion, which suggests growth of 11% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for Hershey’s quarterly earnings has been unchanged in the past 30 days at $2.07 per share. The estimate suggests a 1.4% decline from the year-ago reported number. HSY has delivered an earnings beat of 8.7%, on average, in the trailing four quarters.
Image: Bigstock
What's in Store for International Flavors' (IFF) Q3 Earnings?
International Flavors & Fragrances Inc. (IFF - Free Report) is scheduled to report third-quarter 2022 results on Nov 7 after the closing bell.
Q2 Performance
In the last reported quarter, International Flavors’ earnings and revenues beat the Zacks Consensus Estimates and increased year over year. The company has surpassed earnings estimates in all the trailing four quarters, the average surprise being 12.2%.
International Flavors & Fragrances Inc. Price and EPS Surprise
International Flavors & Fragrances Inc. price-eps-surprise | International Flavors & Fragrances Inc. Quote
Q3 Estimates
The Zacks Consensus Estimate for third-quarter revenues is currently pegged at $3.03 billion, indicating a year-over-year decline of 1.5%. The Zacks Consensus Estimate for the September-end quarter earnings per share is pegged at $1.30, suggesting a year-over-year decline of 11.6%.
Key Factors to Note
International Flavors has been gaining from favorable markets for flavors and fragrances, supported by demand for various consumer products and growth in emerging markets. New business wins and the synergies from the Frutarom acquisition are likely to have aided the company’s performance in the quarter to be reported.
The Nourish segment continues to deliver strong results, primarily driven by the Flavors, Ingredients and Food Design businesses. The Zacks Consensus Estimate for the segment’s sales for the third quarter is pegged at $1,703 million, projecting a 2.5% rise year over year. The consensus mark for the segment’s operating EBITDA is pegged at $328 million compared with the prior-year quarter’s $327 million.
The Scent segment has been witnessing sustained strength in Cosmetic Actives and Consumer Fragrances. Volumes have significantly picked up in the Fine Fragrance business, with consumer behavior returning to normal levels. These are likely to be reflected in the segment’s third-quarter top line.
The Zacks Consensus Estimate for the segment’s sales for the third quarter is currently pegged at $589 million compared with the year-ago quarter’s $580 million. The estimate for operating EBITDA for the segment is at $103 million, indicating year-over-year decline of 21%.
Evolving consumer buying trends are driving demand for the Home & Personal Care business, which might be reflected in the Health & Biosciences segment’s quarterly results. Growth in Grain Processing, Cultures & Food Enzymes and Animal Nutrition is expected to have contributed to the segment’s performance.
The Zacks Consensus Estimate for the Health & Biosciences segment’s sales for the third quarter is pegged at $562 million, suggesting a year-over-year decline of 9%. The estimate for the segment’s operating EBITDA is pegged at $150 million, down 1% from the year-ago quarter.
Strong growth in Industrial Pharma and the ongoing recovery in demand in Pharma are expected to have supported the Pharma Solutions segment in the to-be-reported quarter. The Zacks Consensus Estimate for the segment’s third-quarter sales is pegged at $219 million compared with the prior-year quarter’s $211 million. The estimate for the segment’s operating EBITDA stands at $49 million, indicating a year-over-year increase of 22.5%.
High raw material, energy and labor costs are likely to have impacted the company’s margins in the third quarter. Manufacturing expenses are anticipated to have been higher due to the company’s efforts to meet the current high demand levels.
Labor shortages and supply-chain disruptions might have impacted the company’s production in the to-be-reported quarter. Despite its pricing actions and cost reduction efforts, these factors are likely to have weighed on the company’s margins in the quarter under review.
Earnings Whispers
Our proven model doesn’t conclusively predict an earnings beat for International Flavors this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Earnings ESP: The Earnings ESP for International Flavors is -0.13%.
Zacks Rank: International Flavors currently carries a Zacks Rank #3.
You can see the complete list of today's Zacks #1 Rank stocks here.
Price Performance
Image Source: Zacks Investment Research
In the past year, International Flavors’ shares have declined 33.9% compared with the industry’s fall of 39.7%.
Stocks to Consider
Here are some Consumer Staples stocks,which according to our model have the right combination of elements to post an earnings beat in their upcoming releases:
Dutch Bros (BROS - Free Report) currently has an Earnings ESP of +1.11% and a Zacks Rank #2. The company is expected to register top-line growth when it reports third-quarter 2022 results. The Zacks Consensus Estimate for Dutch Bros’ quarterly revenues is pegged at $196.3 million, indicating an improvement of 51.2% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Dutch Bros’ bottom line has moved down 25% in the past 30 days to 6 cents per share. The estimate suggests a decline of 73.9% from the year-ago quarter’s reported figure. BROS has delivered an earnings beat of 53%, on average, in the trailing four quarters.
US Foods (USFD) currently has an Earnings ESP of +4.58% and a Zacks Rank #2. The company is likely to register top-line growth when it reports third-quarter 2022 numbers. The Zacks Consensus Estimate for quarterly revenues is pegged at $8.6 billion, which suggests growth of 9.6% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for USFD’s third-quarter earnings has moved down 3% in the past 30 days to 59 cents per share. The estimate suggests an improvement of 23% from the year-ago quarter’s reported number.
Hershey (HSY - Free Report) currently has an Earnings ESP of +2.02% and a Zacks Rank of 3. The company is expected to register top-line growth when it reports the third-quarter 2022 numbers. The Zacks Consensus Estimate for HSY’s quarterly revenues is pegged at $2.6 billion, which suggests growth of 11% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for Hershey’s quarterly earnings has been unchanged in the past 30 days at $2.07 per share. The estimate suggests a 1.4% decline from the year-ago reported number. HSY has delivered an earnings beat of 8.7%, on average, in the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.